Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
- Status
- UNKNOWN
- Phase
- PHASE2
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment
- Status
- UNKNOWN
- Phase
- N/A
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE3
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
- Status
- COMPLETED
- Phase
- PHASE2